Hurler‐Scheie patient
Case#: male, 23 year olds (age at report), progressive impairment in ability to perform in school.
DiseaseAssertion: MPS I-H/S
FamilyInfo: N/A
CasePresentingHPOs: Mental deterioration (HP:0001268)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: Yes - the patient had been treated with intravenous rhIDU for 13 years before IT rhIDU and had not undergone HSCT. The patient was also enrolled concurrently in an IRB approved non‐interventional longitudinal study of brain structure and function in MPS at the University of Minnesota. He showed stable or improved neurocognitive outcomes after 24 months of IT rhIDU. The patient showed the greatest improvement in his ability to encode verbal stimuli, moving from significantly impaired to the average level. This was accompanied by a significant improvement in adaptive behavior and an improvement to an above average level, in his ability to remember verbal material in a context. Nonverbal memory, both encoding and recall increased although those scores remained below the average range. A baseline of average IQ and attention performance also somewhat improved.
CaseBMT: No
Variant1: c.979G>C (p.A327P)
Variant1ClinVarID: 167190
Variant1CAID: CA234128
Variant2: c.793G>C (p.G265R)
Variant2ClinVarID: 638074
Variant2CAID: CA2802098
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A